Expression of receptors for advanced glycation end‐products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer
- 3 December 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 196 (2) , 163-170
- https://doi.org/10.1002/path.1031
Abstract
The receptor for advanced glycation end‐products (RAGE) is a newly recognized factor regulating cancer cell invasion and metastasis. This study investigated the expression of RAGE in gastric carcinomas and its association with invasion and metastasis. Of eight gastric cancer cell lines examined, seven constitutively expressed RAGE messenger ribonucleic acid (mRNA), MKN45 being the exception. RAGE protein expression of MKN28 cells treated with RAGE antisense S‐oligodeoxynucleotide was nine times less than that of sense S‐oligodeoxynucleotide‐treated cells. Growth of cells under RAGE antisense S‐oligodeoxynucleotide treatment was not different from that seen under sense S‐oligodeoxynucleotide treatment in MKN28 (a cell line producing high levels of RAGE) and MKN45 (a non‐RAGE‐expressing cell line). RAGE antisense S‐oligodeoxynucleotide treatment suppressed the invasive activity of RAGE‐positive MKN28 cells, as estimated by in vitro invasion assay. The number of MKN28 cells invading the type IV collagen‐coated membrane under RAGE antisense S‐oligodeoxynucleotide treatment was significantly lower than under RAGE sense S‐oligodeoxynucleotide treatment (pS‐oligodeoxynucleotide‐treated RAGE‐negative MKN45 cells showed no difference. A wound‐healing assay showed that no RAGE antisense S‐oligodeoxynucleotide‐treated MKN28 cells migrated into the scraped area, whereas sense S‐oligodeoxynucleotide‐treated cells showed many budding nests in the scraped area. Immunohistochemistry of gastric carcinoma tissue showed that 62 (65%) of the 96 cases examined were RAGE‐positive and that poorly differentiated adenocarcinomas preferentially expressed RAGE protein (38/42, 90%) (pp<0.0001). RAGE‐positive cancer cells tended to be distributed at the invasive front of primary tumours and were detected in all metastatic foci in lymph nodes. In contrast, a major RAGE ligand, amphoterin, was expressed in 82 (85%) of the 96 cases, regardless of histological type and disease progression. RAGE expression appears to be closely associated with invasion and metastasis in gastric cancer. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- Motility and invasion are differentially modulated by Rho family GTPasesOncogene, 2000
- Proteolysis and cell migration: creating a path?Published by Elsevier ,1999
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Cell Migration: A Physically Integrated Molecular ProcessPublished by Elsevier ,1996
- The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for AmphoterinJournal of Biological Chemistry, 1995
- Expression of Receptors for Advanced Glycosylation End Products on Renal Cell Carcinoma Cells in VitroBiochemical and Biophysical Research Communications, 1993
- Aberrant expression of c‐met mRNA in human gastric carcinomasInternational Journal of Cancer, 1993
- Accuracy of cervical smears in predicting the grades of cervical intraepithelial neoplasiaInternational Journal of Gynecologic Cancer, 1993
- Frequent amplification of the c-met gene in scirrhous type stomach cancerBiochemical and Biophysical Research Communications, 1992